NEURIMMUNE
LIVE

Serial Number

79349530

Owner

Neurimmune Holding AG

Attorney

Janice Housey

Filing Date

Jun 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEURIMMUNE Trademark

Serial Number: 79349530 • Registration: 7220623

NEURIMMUNE is a trademark filed by Neurimmune Holding AG on June 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Neurimmune Holding AG (16 trademarks)

Wagistrasse 18

Entity Type: 25

Trademark Details

Filing Date

June 27, 2022

Registration Date

November 21, 2023

Published for Opposition

September 5, 2023

Goods & Services

Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies used for the testing of the disease; vaccines; diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical or veterinary use; sanitary towels for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; anti-bacterial preparations, namely, antibacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; protein food supplements

Medical services; medical services in the field of immunity; providing medical information; medical examinations, namely, physical examinations for medical purposes; pharmaceutical consulting related to the compounding of medicines; wellness and health-related consulting services in the fields of nutrition and diet; consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; veterinary services; beauty salon services; animal care services, namely, veterinary care services; medical consulting services for hygiene in the field of care; medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; medical and pharmaceutical consulting services relating to the preparation of pharmaceutical prescriptions by pharmacists and administration of pharmaceuticals; providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; drug testing, namely, systematic testing of medicinal products for medical use

Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; research in the field of pharmaceutical products, cosmetics and foodstuffs for others; advisory and information services in the field of monitoring and inspection for the quality control and scientific analysis of biologically active chemicals; research in the field of medical treatment and medical methods; research in the field of biotechnology and antibodies; medical and scientific research in the field of clinical trial review and research with regard to medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; software design; computer programming; software maintenance; design and development of computer hardware; software development; consultancy and providing of information with respect to quality control of pharmaceutical products; scientific research in the field of cancerous diseases; scientific research with respect to chemistry

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 18, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 21, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 16, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 16, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 4, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2023 DOCK
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jan 4, 2023 CORR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 4, 2022 NREP
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 16, 2022 CRCV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 7, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 7, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Sep 20, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 15, 2022 REPR